Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey

Vaccine

Volumn 32, Issue 16, 2014, Pages 1848-1855

  Knight Jones, T J D ^a,b   Bulut, A N ^c   Gubbins, S ^a   Stark K D C ^b   Pfeiffer, D U ^b   Sumption, K J ^d   Paton, D J ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c SAP Institute   (Turkey)

^d FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS   (Italy)

Author keywords

Asia 1; Evaluation; FMD; Turkey; Vaccine; Vaccine effectiveness

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE;

AGRICULTURAL WORKER; ANIMAL EXPERIMENT; ARTICLE; CATTLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EFFICACY; ENVIRONMENTAL EXPOSURE; EPIDEMIC; FEMALE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; HUMAN; IMMUNITY; INFECTION CONTROL; INFECTION PREVENTION; MALE; MORBIDITY; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; TURKEY (REPUBLIC); VACCINATION; VIRUS ISOLATION; VIRUS STRAIN;

ASIA-1; EVALUATION; FMD; TURKEY; VACCINE; VACCINE EFFECTIVENESS;

ANIMALS; CATTLE; CATTLE DISEASES; DISEASE OUTBREAKS; FEMALE; FOOT-AND-MOUTH DISEASE; MALE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; TURKEY; VACCINATION; VIRAL VACCINES;

EID: 84895871716     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.071     Document Type: Article

References (19)

1. Knight-Jones T.J.D., Rushton J. The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur?. Prev Vet Med 2013, 112(3-4):161-173.
2. Plotkin S.A., Orenstein W.A., Offit P.A. Vaccines. Offit 2008, Saunders, Philadelphia, PA/London. 5th ed. S.A. Plotkin, W.A. Orenstein, A. Paul (Eds.).
3. Valdazo-Gonzalez B., Polihronova L., Alexandrov T., Normann P., Knowles N.J., Hammond J.M., et al. Reconstruction of the transmission history of RNA virus outbreaks using full genome sequences: foot-and-mouth disease virus in Bulgaria in 2011. PLoS ONE 2012, 7(11):e49650.
4. Askaroglu H. EU project for the control of FMD in Turkey, West Eurasia Roadmap FMD Control 2010-2020, 7-9 October, 2009 - Istanbul, Turkey 2009.
5. Gilbert M., Aktas S., Mohammed H., Roeder P., Sumption K., Tufan M., et al. Patterns of spread and persistence of foot-and-mouth disease types A, O and Asia-1 in Turkey: a meta-population approach. Epidemiol Infect 2005, 133(3):537-545.
6. The Pirbright Institute WRLFMD - FMD vaccine matching strain differentiation report 2011.
7. Alexandersen S., Zhang Z., Donaldson A.I., Garland A.J.M. The pathogenesis and diagnosis of foot-and-mouth disease. J Comp Pathol 2003, 129(1):1-36.
8. Collett D. Modelling binary data 2002, Chapman & Hall/CRC, Boca Raton, FL. 2nd ed.
9. Gelman A., Hill J. Data analysis using regression and multilevel/hierarchical models 2007, Cambridge University Press, Cambridge.
10. R Development Core Team R: a language and environment for statistical computing 2010, R Foundation for Statistical Computing, Vienna, Austria. http://www.r-project.org/.
11. Bates D., Maechler M., Bolker B. lme4: linear mixed-effects models using S4 classes. R package version 0.999999-0 2012, http://cran.r-project.org/package=lme4.
12. Lunn D., Spiegelhalter D., Thomas A., Best N. The BUGS project: evolution, critique, and future directions. Stat Med 2009, 28:3049-3067.
13. OIE Manual of diagnostic tests and vaccines for terrestrial animals 2012 2012, World Organisation for Animal Health, Paris.
14. Jamal S.M., Bouma A., van den Broek J., Stegeman A., Chénard G., Dekker A. Foot-and-mouth disease vaccine potency testing: the influence of serotype, type of adjuvant, valency, fractionation method, and virus culture on the dose-response curve in cattle. Vaccine 2008, 26(50):6317-6321.
15. Li Y., Statham R., Armson B., Hamblin P., Wilsden G., Camping N., et al. Cross protection against current Asia 1 isolates provided by a high potency Asia 1 Shamir vaccine - EUFMD 2012 open session, Jerez, Spain, 29-31 October 2012 2012, http://www.fao.org/fileadmin/user_upload/eufmd/docs/Open_Session2012/Appendices/27_Cross_protection_against_current_Asia_1_field_isolates_provided_by_a_high_potency_Asia_1_Shamir_vaccine___Y._Li_.pdf.
16. Brehm K.E., Kumar N., Thulke H.H., Haas B. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine 2008, 26(13):1681-1687.
17. Brocchi E., Bergmann I.E., Dekker A., Paton D.J., Sammin D.J., Greiner M., et al. Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus. Vaccine 2006, 24(47-48):6966-6979.
18. Woolhouse M.E.J., Haydon D.T., Pearson A., Kitching R.P.P. Failure of vaccination to prevent outbreaks of foot and mouth disease. Epidemiol Infect 1996, 116(3):363-371.
19. Anderson R., May R. The logic of vaccination. New Sci 1982, 96(1332):410-415.